International Stem Cell CORP Debt-to-equity in % from Q3 2019 to Q3 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
International Stem Cell CORP quarterly Debt-to-equity history and growth rate from Q3 2019 to Q3 2025.
  • International Stem Cell CORP Debt-to-equity for the quarter ending September 30, 2025 was -128 %, a 1.55% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)

International Stem Cell CORP Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 -128 -1.96 -1.55% Sep 30, 2025
Q2 2025 -127 +2.26 +1.75% Jun 30, 2025
Q1 2025 -127 +3.67 +2.8% Mar 31, 2025
Q4 2024 -125 +5.02 +3.85% Dec 31, 2024
Q3 2024 -126 +1.96 +1.53% Sep 30, 2024
Q2 2024 -129 -5.86 -4.75% Jun 30, 2024
Q1 2024 -131 -10.2 -8.42% Mar 31, 2024
Q4 2023 -130 -8.83 -7.27% Dec 31, 2023
Q3 2023 -128 -7.81 -6.49% Sep 30, 2023
Q2 2023 -124 -3.35 -2.79% Jun 30, 2023
Q1 2023 -121 +0.66 +0.54% Mar 31, 2023
Q4 2022 -122 +2.51 +2.02% Dec 31, 2022
Q3 2022 -120 +5.9 +4.67% Sep 30, 2022
Q2 2022 -120 +12.2 +9.21% Jun 30, 2022
Q1 2022 -121 +19.5 +13.8% Mar 31, 2022
Q4 2021 -124 +27.8 +18.3% Dec 31, 2021
Q3 2021 -126 +41.3 +24.6% Sep 30, 2021
Q2 2021 -132 +80.9 +37.9% Jun 30, 2021
Q1 2021 -141 +132 +48.3% Mar 31, 2021
Q4 2020 -152 +202 +57.1% Dec 31, 2020
Q3 2020 -168 +4.52K +96.4% Sep 30, 2020
Q2 2020 -213 Jun 30, 2020
Q1 2020 -272 Mar 31, 2020
Q4 2019 -354 Dec 31, 2019
Q3 2019 -4.69K Sep 30, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.